Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone’s Particle Size on Sustained Release
Hydrophilic matrix tablets are a type of sustained release dosage form characterized by distributing a drug in a matrix that is usually polymeric. Tolcapone is a drug that inhibits the enzyme catechol-<i>O</i>-methyl transferase. In recent years, it has been shown that tolcapone is a pot...
Main Authors: | Anna Nardi-Ricart, Isaac Nofrerias-Roig, Marc Suñé-Pou, Pilar Pérez-Lozano, Montse Miñarro-Carmona, Encarna García-Montoya, Josep R. Ticó-Grau, Raul Insa Boronat, Josep M. Suñé-Negre |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/7/674 |
Similar Items
-
Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease
by: Yaquelyn Casanova, et al.
Published: (2022-05-01) -
Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin
by: Jonah A. Moore, et al.
Published: (2020-09-01) -
Right inferior frontal cortex activity correlates with tolcapone responsivity in problem and pathological gamblers
by: Andrew S. Kayser, et al.
Published: (2017-01-01) -
Catechol-o-methyltransferase inhibitor tolcapone improves learning and memory in naïve but not in haloperidol challenged rats
by: Anita Mihaylova, et al.
Published: (2019-06-01) -
The catechol-O-methyltransferase inhibitor, tolcapone, increases the bioavailability of unmethylated (-)-epigallocatechin-3-gallate in mice
by: Sarah C. Forester, et al.
Published: (2015-08-01)